circRNA-0222

N/A

Report date: 2025/09/29 14:28:13
NME

Base Information

Drug NamecircRNA-0222
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Circular RNA
Mechanisms of ActionFibroblast growth factor 21 modulators
TargetsFibroblast growth factor 21
Therapy Area/IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTherorna Inc
China Registration ClassN/A

Develop Information

Active CompaniesTherorna Inc
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A